Skip to Main Content

Author Details

Jiayu Liang
institute of urology
2016
63
13
PMIDPaper TitleJournal TitlePublished Year
37847513Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.Cancer Res2024
36376185The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer.Asian J Surg2023
37793855Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma.J Immunother Cancer2023
37608295The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma.Diagn Pathol2023
37415738Mutations in epigenetic regulator <i>KMT2C</i> detected by liquid biopsy are associated with worse survival in prostate cancer patients.Oncol Res2023
37404997Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.Ann Transl Med2023
37007568The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.Ann Transl Med2023
37131267Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma.Genome Med2023
36907910Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.J Cancer Res Clin Oncol2023
36865786Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients.J Multidiscip Healthc2023
34185954Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.BJU Int2022
35733094Should preoperative computed tomography be routine examination for cervicofacial space infections?BMC Infect Dis2022
35790516[Application of Broadrick occlusal plane analyzer in the functional and esthetic rehabilitation of a patient with severe dental erosion].Zhonghua Kou Qiang Yi Xue Za Zhi2022
36578496Serum uric acid as a risk factor for rejection after deceased donor kidney transplantation: A mono-institutional analysis of paired kidneys.Front Immunol2022
35941663Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.Clin Epigenetics2022
36247012Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma.Front Cell Dev Biol2022
35969149The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism.FASEB J2022
35864546Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).BMC Med2022
36362527Risk Factors for Maxillary Sinus Pathology after Surgery for Midfacial Fracture: A Multivariate Analysis.J Clin Med2022
35992138Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma.Front Endocrinol (Lausanne)2022
36128328Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.Oncotarget2022
36386587Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma.J Inflamm Res2022
36082136Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient's CDK12 Mutation: A Case Report.Onco Targets Ther2022
35187953Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.Immunotherapy2022
35281080Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.Front Cell Dev Biol2022
35275862Prevalence and Risk Factors for Chronic Maxillary Sinusitis After Surgery for Mid-Facial Fracture: A Cross-Sectional Study.J Craniofac Surg2022
35115934Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis.Front Pharmacol2022
33414138Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.Clin Cancer Res2021
33842369The Role of CD276 in Cancers.Front Oncol2021
33725913Clinical significance of prognostic nutritional index in renal cell carcinomas.Medicine (Baltimore)2021
34975480Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.Front Pharmacol2021
34435696The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.Prostate2021
34489456Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.Nat Commun2021
34445989Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.BMC Cancer2021
34105799Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis.FASEB J2021
33937065A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma.Front Oncol2021
34318630Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: Association with patient outcome under abiraterone.Cancer Med2021
34028061Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients.Prostate2021
34194432Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation.Front Immunol2021
33279225Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.Surgery2021
33184944Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients.J Oral Pathol Med2021
32420177Development of nanotechnology in andrology.Transl Androl Urol2020
31786772The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.Endocrine2020
31998416Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.Dis Markers2020
33024233Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.Sci Rep2020
30569143Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo.Mol Med Rep2019
31783819Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.BMC Cancer2019
31004655Increased expression of miR-155 correlates with abnormal allograft status in solid organ transplant patients and rat kidney transplantation model.Life Sci2019
31080125Re: Catherine H. Marshall, Alexandra O. Sokolova, Andrea L. McNatty, et al. Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations. Eur Urol 2019;76:452-8.Eur Urol2019
29180799Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies.Int J Impot Res2018
  • 1 - 50 of 63

Recommended Authors

Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 1
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Peking University People's Hospital
Career Start Year 2012
Number of shared co-authors 0
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year 2011
Number of shared co-authors 1
Chiba University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2010
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 1
Shanghai Changzheng Hospital
Career Start Year 2007
Number of shared co-authors 1
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year 2006
Number of shared co-authors 1
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 1
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Fudan University Shanghai Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 0
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 1
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0

Collaborators

Yale University School of Medicine
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Institute of Urologic Oncology, University of California los angeles
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Stomatology Hospital, Zhejiang University School of Medicine
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Institute of Urologic Oncology, University of California Los Angeles
Co-authored papers 1
Yale University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Yale University
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Karmanos Cancer Institute, Wayne State University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
College of Optical Science and Engineering, Zhejiang University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1